The main objective is to examine the relationship between energy cost and (1) hip extensor and knee extensor co-activation, (2) plantar flexor and hip extensor co-activation and (3) plantar flexor and knee extensor co-activation in able-bodied…
ID
Source
Brief title
Condition
- Neuromuscular disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Muscle co-activation measured by surface electromyography (Delsys 16-channel
sEMG system, Natick, MA, USA) and energy cost measured by breath-to-breath
analysis (K5, Cosmed, Rome, IT).
Secondary outcome
Kinematic description of the movements measured with a 10-camera motion capture
system (Vicon Motion Systems Ltd, Yarnton, UK).
Background summary
Individuals post stroke show higher energy cost of walking compared to
able-bodied individuals. Although several factors such as an increase in
mechanical work, step length asymmetry and impaired balance control have been
associated to contribute to this increased energy cost, the underlying
mechanism remains unclear. The remaining impairments in motor control are
related to functional deficits of walking and might explain a part of the
increased energy cost of walking. These impairments manifest in an impaired
ability to independently control individual muscles due to neural constraints,
i.e. reduced selective control. Co-activation of the ankle plantar flexor
muscles with knee- and hip-extensor muscles reflects this reduced selective
control after stroke. Indeed, age-related adaptations in muscle co-activation
patterns have shown to be related to the increased energy cost of walking in
older adults. However, muscle co-activation could also serve as compensatory
strategy to increase stability during walking post-stroke, due to task
constraints of walking. To distinguish the neural constraints (reduced
selective control) from task constraints (co-activation as a stability strategy
in gait) after stroke, we will assess muscle co-activation during an isolated
leg swinging task and compared this to muscle co-activation during walking. We
hypothesise that there is a relationship between muscle co-activation during
isolated leg swinging and walking, which explains the increased energy cost of
walking in people post-stroke, but not in healthy adults.
Study objective
The main objective is to examine the relationship between energy cost and (1)
hip extensor and knee extensor co-activation, (2) plantar flexor and hip
extensor co-activation and (3) plantar flexor and knee extensor co-activation
in able-bodied individuals and individuals post stroke during an isolated swing
movement of the leg.
The secondary objective is to examine the relationship between energy cost and
(1) hip extensor and knee extensor co-activation, (2) plantar flexors and
quadriceps co-activation and (3) plantar flexor and quadriceps co-activation
during walking.
The third objective is to examine whether the co-activation during the isolated
swing movement of the paretic leg explains increased energy cost during walking.
Both a younger (18-25 years) and older (50-75 years) able-bodied control group
will be assessed, to be able to distinguish between-group differences due to
age from between-group differences due to stroke.
Study design
This study is conducted as pilot study with a quasi-experimental study design.
Participants will perform three walking tasks on a treadmill and three leg
swinging tasks. Walking will be performed in three different speed conditions:
1) Comfortable walking speed (CWS), 2) Fixed walking speed (FWS; 0,6 m/s
normalized to leg length) and 3) increased walking speed (IWS = CWS x 1.3). The
three leg swinging tasks will be pace-matched to the leg-swinging frequency
during each respective walking condition. For safety, participants will wear a
safety harness attached to the ceiling to prevent them from falling during all
tasks.
Study burden and risks
In total, 36 participants are tested on one occasion which will take about
three hours. A very minimal risk of discomforts to participants is expected
from participation in the study.
Antonius Deusinglaan 1
Groningen 9713AV
NL
Antonius Deusinglaan 1
Groningen 9713AV
NL
Listed location countries
Age
Inclusion criteria
Individuals post stroke (n = 12)
- Diagnosis of stroke at least 6 months prior to testing.
- Age between 18 and 75 years old.
- Able to walk independently for a minimum of 6 minutes without an assistive
device, manual assistance or walking aids.
- Paresis on one side of the body (hemiparesis).
Able-bodied young adults (n = 12)
- Age between 18 and 25 years old.
Able- bodied older adults (n = 12)
- Age between 50 and 75 years old.
Exclusion criteria
Individuals post stroke (n = 12)
- Unable to understand the study instructions in Dutch.
- Unable to execute the study instructions.
- Having received a botulinum toxin injection in the lower extremities within
12 weeks prior to testing.
- Indications of orthopaedic, neurological, cardiorespiratory and behavioral
conditions other than stroke that may affect gait.
Healthy young and older adults (2 x n = 12)
- Unable to understand the study instructions in Dutch.
- Indications of orthopaedic, neurological, cardiorespiratory and behavioral
conditions that may affect gait.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL83016.042.22 |